NFNathaniel M. Fried

Nathaniel M. Fried

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nathaniel M. Fried has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of germanium oxide fibers with silica and sapphire fiber tips for transmission of erbium: YAG laser radiation

    by Travis J. Polletto, Anthony K. Ngo, Alexei Tchapyjnikov, Ken Levin, Danh Tran, Nathaniel M. Fried

    Background and Objectives Endoscopic applications of the Erbium:YAG laser have been limited due to the lack of a suitable optical fiber delivery system. The purpose of this study was to compare the transmission of Er:YAG laser radiation through germanium oxide trunk fibers with silica and sapphire fiber tips for potential use in contact tissue ablation during endoscopy. Study Design/Materials and Methods Er:YAG laser radiation with a wavelength of 2.94 µm, pulse length of 300 microseconds, pulse energies from 5 to 1,360 mJ, coupled into pulse repetition rates of 3–10 Hz, was through 1‐m‐long germanium oxide fibers with either 1‐cm‐long, 550‐µm‐diameter silica or sapphire tips. Results Transmission through the germanium oxide/sapphire fibers measured 65±5% compared with 55±4% for the germanium oxide/silica fibers (Pn = 7 fibers each) (P<0.05). The highest pulse energies transmitted through the fibers were 700 mJ and 220 mJ, respectively. Conclusions Improved index‐matching of the trunk fiber and fiber tip at 2.94 µm resulted in higher transmission and damage thresholds for the germanium oxide/sapphire fibers. The germanium oxide/sapphire fiber may represent a promising mid‐infrared optical fiber delivery system for use in endoscopic applications of the Er:YAG laser requiring a flexible, biocompatible, and robust fiber delivery system for contact tissue ablation. Lasers Surg. Med. 38:787–791, 2006.


  • Therapeutic applications of lasers in urology: an update

    by Nathaniel M Fried

    There has been renewed interest in the use of lasers for minimally invasive treatment of urologic diseases in recent years. The introduction of more compact, higher power, less expensive and more user-friendly solid-state lasers, such as the holmium:yttrium-aluminum-garnet (YAG), frequency-doubled neodymium:YAG and diode lasers has made the technology more attractive for clinical use. The availability of small, flexible, biocompatible, inexpensive and disposable silica optical fiber delivery systems for use in flexible endoscopes has also promoted the development of new laser procedures. The holmium:YAG laser is currently the workhorse laser in urology since it can be used for multiple soft- and hard-tissue applications, including laser lithotripsy, benign prostate hyperplasia, bladder tumors and strictures. More recently, higher power potassium-titanyl-phosphate lasers have been introduced and show promise for the treatment of benign prostatic hyperplasia. On the horizon, newer and more effective photosensitizing drugs are being tested for potential use in photodynamic therapy of bladder and prostate cancer. Additionally, new experimental lasers such as the erbium:YAG, Thulium and Thulium fiber lasers, may provide more precise incision of soft tissues, more efficient laser lithotripsy and more rapid prostate ablation. This review provides an update on the most important new clinical and experimental therapeutic applications of lasers in urology over the past 5 years.


  • Thulium fiber laser lithotripsy: An in vitro analysis of stone fragmentation using a modulated 110-watt Thulium fiber laser at 1.94 µm

    by Nathaniel M. Fried

    Background and Objectives The high-power Thulium fiber laser has previously been shown to rapidly vaporize and coagulate soft urinary tissues (e.g., prostate). This is the first preliminary study of a high-power Thulium fiber laser for fragmentation of urinary stones. Study Design/Materials and Methods A continuous-wave, high-power Thulium fiber laser operating at a wavelength of 1.94 µm, was modulated to operate in pulsed mode with an output pulse energy of 1 J through a 300-µm-core silica fiber at a 20 milliseconds pulse length and repetition rate of 10 Hz. The fragmentation time to reduce uric acid (UA) (n = 13) and calcium oxalate monohydrate (COM) (n = 6) stones into particles < 2 mm was measured. Results Mean initial mass of the UA and COM stones measured 860±211 and 763 ± 204 mg. Fragmentation rates measured 388 ± 49 and 25 ± 2 mg/minute. Average time needed to fragment the UA and COM stones into particles < 2 mm was 2.25 ± 0.63 and 30.7 ± 8.4 minutes, respectively. Conclusions The high-power Thulium fiber laser, when operated in pulsed mode, is capable of fragmenting both soft (UA) and hard (COM) urinary stones. The Thulium fiber laser may be useful as a single laser system for use in multiple soft and hard tissue laser ablation applications in urology. Lasers Surg. Med.


  • High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 ?m

    by Nathaniel M. Fried

    Introduction The Thulium fiber laser may have several advantages over current urology lasers, including smaller size, more efficient operation, improved spatial beam quality, more precise tissue incision, and operation in pulsed or continuous-wave modes. Previous laser-tissue interaction studies utilizing the Thulium fiber laser have been limited to laser powers of less than 5 W, restricting potential medical applications. This study describes the preliminary testing of a high-power Thulium fiber laser for vaporization of the canine prostate, ex vivo. Study Design/Materials and Methods A continuous-wave, 110-W Thulium fiber laser operating at a wavelength of 1.91 μm, delivered 88.5±2.3 W of power through a 600-μm-core silica fiber for non-contact vaporization of canine prostates (n = 6). Results The Thulium fiber laser vaporized prostate tissue at a rate of 0.83±0.11 g/minute. The thermal coagulation zone measured 500–2,000 μm, demonstrating the potential for hemostasis. Conclusions The high-power Thulium fiber laser is capable of rapid vaporization and coagulation of the prostate. In vivo animal studies are currently being planned for evaluation of the Thulium fiber laser for potential treatment of benign prostate hyperplasia (BPH). Lasers Surg. Med. 36:52–56, 2005.


  • Top Cited Papers

    High-Power Thulium Fiber Laser Ablation of Urinary Tissues at 1.94 µm

    by Nathaniel M. Fried, Keith E. Murray

    Purpose: This paper describes the preliminary testing of a new laser, the thulium fiber laser, as a potential replacement for the holmium:YAG laser for multiple applications in urology. Materials and Methods: A 40 W thulium fiber laser operating at a wavelength of 1.94 µm delivered radiation in a continuous-wave or pulsed mode (10 msec) through either 300-µm- or 600-µm-core low-OH silica fibers for vaporization of canine prostate and incision of animal ureter and bladder-neck tissues. Results: The thulium fiber laser vaporized prostate tissue at a rate of 0.21 ± 0.02 g/min. The thermal-coagulation zone measured 500 to 2000 µm, demonstrating the potential for hemostasis. Laser incisions were also made in bladder tissue and ureter, with coagulation zones of 400 to 600 µm. Conclusions: The thulium fiber laser has several potential advantages over the holmium laser, including smaller size, more efficient operation, more precise incision of tissues, and operation in either the pulsed or the continuous-wave mode. However, before clinical use will be possible, development of higher-power thulium fiber lasers and shorter pulse lengths will be necessary for rapid vaporization of the prostate and more precise incision of urethral/bladder-neck strictures, respectively.


  • Subsurface tissue lesions created using an Nd:YAG laser and a sapphire contact cooling probe

    by Rahayu Ramli, Chia‐Chun Chung, Nathaniel M. Fried, Nicholas Franco, Michael H. Hayman

    Background and Objectives This study investigates deep laser coagulation of tissue in combination with contact cooling of the tissue surface for potential use in noninvasive procedures in urology. Study Design/Materials and Methods A laser probe was designed and tested for simultaneous Nd:YAG laser irradiation and sapphire contact cooling of liver and skin tissue samples, ex vivo. Gross and histologic examination was used to quantify thermal lesion dimensions. Results Liver lesions measured 5.5 ± 0.3 mm in diameter, while preserving the tissue surface to a depth of 2.1 ± 0.2 mm (n = 5). Skin lesions measured 4.3 ± 0.9 mm in diameter, while preserving the skin surface to a depth of 1.1 ± 0.2 mm (n = 6). There were no statistical differences in lesion diameter and layer of preserved tissue between contact (sapphire) cooling and prior non-contact (cryogen spray) cooling results for a given tissue type (P > 0.05). Conclusions Noninvasive laser procedures targeting tissue structures for thermal coagulation within a few millimeters of the tissue surface are feasible and may expand the use of combined laser/cooling techniques for applications in urology and general surgery. In vivo animal studies are currently in development to optimize the laser and cooling parameters for potential clinical applications. Lasers Surg. Med. 35:392–396, 2004.


  • Hybrid germanium/silica optical fibers for endoscopic delivery of erbium:YAG laser radiation

    by Charles A. Chaney, Yubing Yang, Nathaniel M. Fried

    Background and Objectives: Endoscopic applications of the erbium (Er):YAG laser have been limited due to the lack of an optical fiber delivery system that is robust, flexible, and biocompatible. This study reports the testing of a hybrid germanium/silica fiber capable of delivering Er:YAG laser radiation through a flexible endoscope.Study Design/Materials and Methods: Hybrid optical fibers were assembled from 1‐cm length, 550‐μm core, silica fiber tips attached to either 350‐ or 425‐μm germanium oxide “trunk” fibers. Er:YAG laser radiation (λ = 2.94 μm) with laser pulse lengths of 70 and 220 microseconds, pulse repetition rates of 3–10 Hz, and laser output energies of up to 300 mJ was delivered through the fibers for testing.Results: Maximum fiber output energies measured 180±30 and 82±20 mJ (n = 10) under straight and tight bending configurations, respectively, before fiber interface damage occurred. By comparison, the damage threshold for the germanium fibers without silica tips during contact soft tissue ablation was only 9 mJ (n = 3). Studies using the hybrid fibers for lithotripsy also resulted in fiber damage thresholds (55–114 mJ) above the stone ablation threshold (15–23 mJ).Conclusions: Hybrid germanium/silica fibers represent a robust, flexible, and biocompatible method of delivering Er:YAG laser radiation during contact soft tissue ablation. However, significant improvement in the hybrid fibers will be necessary before they can be used for efficient Er:YAG laser lithotripsy. Lasers Surg. Med. 34:5–11, 2004.


  • Optimization of the Erbium:YAG laser for precise incision of ureteral and urethral tissues: In vitro and in vivo results

    by Nathaniel M. Fried, Zelalem Tesfaye, Albert M. Ong, Koon H. Rha, Pooya Hejazi

    Background and Objectives: Tissue damage during endoscopic treatment of urethral and ureteral strictures may result in stricture recurrence. The Erbium:YAG laser ablates soft tissues with minimal peripheral damage and may be a promising alternative to cold knife and Holmium:YAG laser for precise incision of urological strictures.Study Design/Materials and Methods: Optimization of the Er:YAG laser was conducted using ex vivo porcine ureteral and canine urethral tissues. Preliminary in vivo studies were also performed in a laparoscopic porcine ureteral model with exposed ureter. Laser radiation with a wavelength of 2.94 μm, pulse lengths of 8, 70, and 220 micro seconds, output energies of 2–35 mJ, fluences of 1–25 J/cm2, and pulse repetition rates of 5–30 Hz, was delivered through 250‐μm and 425‐μm core germanium oxide optical fibers in direct contact with tissue.Results: Ex vivo perforation thresholds measured 2–4 J/cm2, with ablation rates of 50 μm/pulse at fluences of 6–11 J/cm2. In vivo perforation thresholds were approximately 1.8 J/cm2, with the ureter perforated in less than 20 pulses at fluences greater than 3.6 J/cm2. Peripheral thermal damage in tissue decreased from 30 to 60 μm to 10–20 μm as the laser pulse length decreased from 220 to 8 microseconds. Mechanical tissue damage was observed at the 8 microseconds pulse duration.Conclusions: The Er:YAG laser, operating at a pulse duration of ∼70 microseconds, a fluence greater than ∼4 J/cm2, and a repetition rate less than 20 Hz, is capable of rapidly incising urethral and ureteral tissues with minimal thermal and mechanical side‐effects. Lasers Surg. Med. 33:108–114, 2003.


  • Focused ultrasound ablation of the epididymis with use of thermal measurements in a canine model

    by Nathaniel M Fried, William W Roberts, Yegor D Sinelnikov, E.James Wright, Stephen B Solomon


    • 1 June 2002
      • Vol. 167  (6) , 2613-7

    High intensity focused ultrasound ablation of the vas deferens in a canine model.

    by William W Roberts, David Y Chan, Nathaniel M Fried, E James Wright, Theresa Nicol, Thomas W Jarrett, Louis R Kavoussi, Stephen B Solomon

    High intensity focused ultrasound is an ablative technology capable of producing thermal coagulative necrosis of sub-surface structures without injuring intervening tissues. We assessed the feasibility of using high intensity focused ultrasound to produce occlusion of the canine vas deferens. A high intensity focused ultrasound transducer was incorporated into a hand held clip specially designed to grasp the vas deferens transcutaneously. Slots within the jaws of the clip ensured that the vas deferens and high intensity focused ultrasound target zone were properly co-located. We ablated 10 vasa using a range of power and time parameters. At 2 weeks after ablation each vas, epididymis and testis was surgically harvested en bloc. Retrograde vasography was performed to assess vasal occlusion, followed by pathological analysis. High intensity focused ultrasound occlusion of the vas deferens was confirmed in 4 specimens ablated with parameters at the upper end of the parameter range, 2 of the 2 ablated with 7 W. for 60 seconds and 2 of the 4 ablated with 7 W. for 30 seconds. Histological injury was noted in 8 of the 10 ablated specimens. Skin burns that developed over 4 of the targeted vasa were conservatively managed. Bilateral sham procedures in a control dog resulted in patent vasa and no associated skin burns. We demonstrated the feasibility of noninvasive, transcutaneous high intensity focused ultrasound occlusion of the vas deferens with ablation powers at the upper end of the tested range, that is 7 W. Modifications of the hand held clip and optimization of ablation parameters would likely improve the success rate of this procedure. Refinement of this technology may provide a rapid noninvasive alternative to conventional vasectomy.